Download PDF
J Reconstr Microsurg 2022; 38(08): 630-636
DOI: 10.1055/s-0042-1742732
Original Article

Indocyanine Green Lymphography for Evaluation of Breast Lymphedema Secondary to Breast Cancer Treatments

Takumi Yamamoto
1   Department of Plastic and Reconstructive Surgery, National Center for Global Health and Medicine, Tokyo, Japan
2   Department of Plastic Surgery, Tokyo Metropolitan Bokutoh Hospital, Tokyo, Japan
3   Department of Plastic Surgery, Noda Hospital, Chiba, Japan
,
Nana Yamamoto
1   Department of Plastic and Reconstructive Surgery, National Center for Global Health and Medicine, Tokyo, Japan
2   Department of Plastic Surgery, Tokyo Metropolitan Bokutoh Hospital, Tokyo, Japan
› Author Affiliations
› Further Information
    Permissions and Reprints

Abstract

Background Although breast lymphedema (BL) significantly deteriorates quality of life (QOL) of breast cancer survivors, little is known and pathophysiological severity staging system is yet reported. This study aimed to evaluate usefulness of a novel BL severity staging system based on indocyanine green (ICG) lymphography findings.

Methods Breast cancer survivors with breast symptoms who underwent breast ICG lymphography were included. Breast ICG lymphography stage was determined based on visibility of linear pattern and extension of dermal backflow patterns. Prevalence of breast symptoms and lymphedema QOL score (LeQOLiS) was compared according to the stage.

Results Thirty-seven patients were included. Breast ICG lymphography stage included stage 0 in 11 (29.7%) cases, stage I in 3 (8.1%) cases, stage II in 11 (29.7%) cases, stage III in 6 (16.2%) cases, stage IV in 4 (10.8%) cases, and stage V in 2 (5.4%) cases. Higher ICG stages were associated with more frequent prevalence of breast swelling (p = 0.020), breast pain (p = 0.238), and breast cellulitis (p = 0.024), and with higher LeQOLiS (p < 0.001).

Conclusion ICG lymphography allows clear visualization of superficial lymph circulation in the breast. Higher breast ICG lymphography stages are associated with more frequent prevalence of BL-related symptoms and worse QOL.

Keywords

lymphedema - indocyanine green - breast cancer - supermicrosurgery - anastomosis


Publication History

Received: 03 August 2021

Accepted: 26 December 2021

Article published online:
08 February 2022

© 2022. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Runowicz CD, Leach CR, Henry NL. et al. American Cancer Society/American Society of clinical oncology breast cancer survivorship care guideline. J Clin Oncol 2016; 34 (06) 611-635
    CrossrefPubMedGoogle Scholar
  • 2 Taghian NR, Miller CL, Jammallo LS, O'Toole J, Skolny MN. Lymphedema following breast cancer treatment and impact on quality of life: a review. Crit Rev Oncol Hematol 2014; 92 (03) 227-234
    CrossrefPubMedGoogle Scholar
  • 3 Panchik D, Masco S, Zinnikas P. et al. Effect of exercise on breast cancer-related lymphedema: what the lymphatic surgeon needs to know. J Reconstr Microsurg 2019; 35 (01) 37-45
    Article in Thieme ConnectPubMedGoogle Scholar
  • 4 Yamamoto T, Yamamoto N, Doi K. et al. Indocyanine green-enhanced lymphography for upper extremity lymphedema: a novel severity staging system using dermal backflow patterns. Plast Reconstr Surg 2011; 128 (04) 941-947
    CrossrefPubMedGoogle Scholar
  • 5 Cheng MH, Chen SC, Henry SL, Tan BK, Chia-Yu Lin M, Huang JJ. Vascularized groin lymph node flap transfer for postmastectomy upper limb lymphedema: flap anatomy, recipient sites, and outcomes. Plast Reconstr Surg 2013; 131 (06) 1286-1298
    CrossrefPubMedGoogle Scholar
  • 6 Chang DW, Suami H, Skoracki R. A prospective analysis of 100 consecutive lymphovenous bypass cases for treatment of extremity lymphedema. Plast Reconstr Surg 2013; 132 (05) 1305-1314
    CrossrefPubMedGoogle Scholar
  • 7 Fish ML, Grover R, Schwarz GS. Quality-of-life outcomes in surgical vs nonsurgical treatment of breast cancer-related lymphedema: a systematic review. JAMA Surg 2020; 155 (06) 513-519
    CrossrefPubMedGoogle Scholar
  • 8 Dorogi B, Bukovszky B, Mátrai T. et al. Mapping of the functional anatomy of lymphatic drainage to the axilla in early breast cancer: A cohort study of 933 cases. Eur J Surg Oncol 2019; 45 (02) 103-109
    CrossrefPubMedGoogle Scholar
  • 9 Scaglioni MF, Meroni M, Fritsche E. Lymphovenous anastomosis (LVA) for treatment of secondary breast lymphedema: a case report and literature review. Microsurgery 2021; 41 (02) 165-169
    CrossrefPubMedGoogle Scholar
  • 10 Giacalone G, Yamamoto T, Belva F, Wets R, Hayashi A, Koshima I. Successful treatment of breast cancer-related breast lymphedema by lymphovenous anastomosis in a male patient. Microsurgery 2019; 39 (04) 360-363
    CrossrefPubMedGoogle Scholar
  • 11 Yamamoto T, Yamamoto N, Giacalone G. Supermicrosurgical lymphaticovenular anastomosis for a breast lymphedema secondary to vascularized axillary lymph node flap transfer. Lymphology 2016; 49 (03) 128-132
    PubMedGoogle Scholar
  • 12 Abouelazayem M, Elkorety M, Monib S. Breast lymphedema after conservative breast surgery: an up-to-date systematic review. Clin Breast Cancer 2021; 21 (03) 156-161
    CrossrefPubMedGoogle Scholar
  • 13 Ganju RG, Savvides G, Korentager S. et al. Incidence of breast lymphedema and predictors of its development in patients receiving whole breast radiation therapy after breast-conservation surgery. Lymphology 2019; 52 (03) 126-133
    CrossrefPubMedGoogle Scholar
  • 14 Yamamoto T, Koshima I. Subclinical lymphedema: understanding is the clue to decision making. Plast Reconstr Surg 2013; 132 (03) 472e-473e
    CrossrefPubMedGoogle Scholar
  • 15 Abdou Y, Elkhanany A, Attwood K, Ji W, Takabe K, Opyrchal M. Primary and secondary breast angiosarcoma: single center report and a meta-analysis. Breast Cancer Res Treat 2019; 178 (03) 523-533
    CrossrefPubMedGoogle Scholar
  • 16 Yamamoto T, Iida T, Matsuda N. et al. Indocyanine green (ICG)-enhanced lymphography for evaluation of facial lymphoedema. J Plast Reconstr Aesthet Surg 2011; 64 (11) 1541-1544
    CrossrefPubMedGoogle Scholar
  • 17 Yamamoto T, Yamamoto N, Yoshimatsu H, Hayami S, Narushima M, Koshima I. Indocyanine green lymphography for evaluation of genital lymphedema in secondary lower extremity lymphedema patients. J Vasc Surg Venous Lymphat Disord 2013; 1 (04) 400-405.e1
    CrossrefPubMedGoogle Scholar
  • 18 Mikami T, Hosono M, Yabuki Y. et al. Classification of lymphoscintigraphy and relevance to surgical indication for lymphaticovenous anastomosis in upper limb lymphedema. Lymphology 2011; 44 (04) 155-167
    PubMedGoogle Scholar
  • 19 Yamamoto T, Yamamoto N, Fuse Y, Narushima M, Koshima I. Optimal sites for supermicrosurgical lymphaticovenular anastomosis: an analysis of lymphatic vessel detection rates on 840 surgical fields in lower extremity lymphedema. Plast Reconstr Surg 2018; 142 (06) 924e-930e
    CrossrefPubMedGoogle Scholar
  • 20 Yamamoto T, Yamamoto N, Yoshimatsu H, Narushima M, Koshima I. Factors associated with lymphosclerosis: an analysis on 962 lymphatic vessels. Plast Reconstr Surg 2017; 140 (04) 734-741
    CrossrefPubMedGoogle Scholar
  • 21 Yamamoto T, Narushima M, Koshima I. Lymphatic vessel diameter in female pelvic cancer-related lower extremity lymphedematous limbs. J Surg Oncol 2018; 117 (06) 1157-1163
    CrossrefPubMedGoogle Scholar
  • 22 Yamamoto T, Narushima M, Doi K. et al. Characteristic indocyanine green lymphography findings in lower extremity lymphedema: the generation of a novel lymphedema severity staging system using dermal backflow patterns. Plast Reconstr Surg 2011; 127 (05) 1979-1986
    CrossrefPubMedGoogle Scholar
  • 23 Yamamoto T, Matsuda N, Doi K. et al. The earliest finding of indocyanine green lymphography in asymptomatic limbs of lower extremity lymphedema patients secondary to cancer treatment: the modified dermal backflow stage and concept of subclinical lymphedema. Plast Reconstr Surg 2011; 128 (04) 314e-321e
    CrossrefPubMedGoogle Scholar
  • 24 Yamamoto T, Narushima M, Yoshimatsu H. et al. Dynamic indocyanine green (ICG) lymphography for breast cancer-related arm lymphedema. Ann Plast Surg 2014; 73 (06) 706-709
    CrossrefPubMedGoogle Scholar
  • 25 Yamamoto T, Narushima M, Yoshimatsu H. et al. Indocyanine green velocity: lymph transportation capacity deterioration with progression of lymphedema. Ann Plast Surg 2013; 71 (05) 591-594
    CrossrefPubMedGoogle Scholar
  • 26 Yamamoto T, Narushima M, Yoshimatsu H. et al. Minimally invasive lymphatic supermicrosurgery (MILS): indocyanine green lymphography-guided simultaneous multisite lymphaticovenular anastomoses via millimeter skin incisions. Ann Plast Surg 2014; 72 (01) 67-70
    CrossrefPubMedGoogle Scholar
  • 27 Yamamoto T. Onco-reconstructive supermicrosurgery. Eur J Surg Oncol 2019; 45 (07) 1146-1151
    CrossrefPubMedGoogle Scholar
  • 28 Yamamoto T, Yamamoto N, Kageyama T. et al. Technical pearls in lymphatic supermicrosurgery. Glob Health Med 2020; 2 (01) 29-32
    CrossrefPubMedGoogle Scholar
  • 29 Yamamoto T, Yamamoto N, Sakai H. et al. Lymphedema quality of life score (LeQOLiS): a simple method for evaluation of subjective symptoms in extremity lymphedema patients. Plast Reconstr Surg 2018; DOI: 10.1097/PRS.0000000000004937.
    CrossrefPubMedGoogle Scholar
  • 30 Brahma B, Yamamoto T. Breast cancer treatment-related lymphedema (BCRL): An overview of the literature and updates in microsurgery reconstructions. Eur J Surg Oncol 2019; 45 (07) 1138-1145
    CrossrefPubMedGoogle Scholar
  • 31 Akita S, Mitsukawa N, Kazama T. et al. Comparison of lymphoscintigraphy and indocyanine green lymphography for the diagnosis of extremity lymphoedema. J Plast Reconstr Aesthet Surg 2013; 66 (06) 792-798
    CrossrefPubMedGoogle Scholar
  • 32 O'Donnell Jr TF, Rasmussen JC, Sevick-Muraca EM. New diagnostic modalities in the evaluation of lymphedema. J Vasc Surg Venous Lymphat Disord 2017; 5 (02) 261-273
    CrossrefPubMedGoogle Scholar
  • 33 Executive Committee of the International Society of Lymphology. The diagnosis and treatment of peripheral lymphedema: 2020 Consensus Document of the International Society of Lymphology. Lymphology 2020; 53 (01) 3-19
    PubMedGoogle Scholar
  • 34 Yamamoto T, Yoshimatsu H, Yamamoto N. Complete lymph flow reconstruction: a free vascularized lymph node true perforator flap transfer with efferent lymphaticolymphatic anastomosis. J Plast Reconstr Aesthet Surg 2016; 69 (09) 1227-1233
    CrossrefPubMedGoogle Scholar
  • 35 Yamamoto T, Yamamoto N, Yoshimatsu H, Narushima M, Koshima I. Factors associated with lower extremity dysmorphia caused by lower extremity lymphedema. Eur J Vasc Endovasc Surg 2017; 54 (01) 69-77
    CrossrefPubMedGoogle Scholar
  • 36 Yamamoto T, Iida T, Yoshimatsu H, Fuse Y, Hayashi A, Yamamoto N. Lymph flow restoration after tissue replantation and transfer: importance of lymph axiality and possibility of lymph flow reconstruction using free flap transfer without lymph node or supermicrosurgical lymphatic anastomosis. Plast Reconstr Surg 2018; 142 (03) 796-804
    CrossrefPubMedGoogle Scholar
  • 37 Yamamoto T, Narushima M, Kikuchi K. et al. Lambda-shaped anastomosis with intravascular stenting method for safe and effective lymphaticovenular anastomosis. Plast Reconstr Surg 2011; 127 (05) 1987-1992
    CrossrefPubMedGoogle Scholar
  • 38 Suami H, Heydon-White A, Mackie H, Czerniec S, Koelmeyer L, Boyages J. A new indocyanine green fluorescence lymphography protocol for identification of the lymphatic drainage pathway for patients with breast cancer-related lymphoedema. BMC Cancer 2019; 19 (01) 985
    CrossrefPubMedGoogle Scholar
  • 39 Yamamoto T, Yoshimatsu H, Koshima I. Navigation lymphatic supermicrosurgery for iatrogenic lymphorrhea: supermicrosurgical lymphaticolymphatic anastomosis and lymphaticovenular anastomosis under indocyanine green lymphography navigation. J Plast Reconstr Aesthet Surg 2014; 67 (11) 1573-1579
    CrossrefPubMedGoogle Scholar
  • 40 Koelmeyer LA, Thompson BM, Mackie H. et al. Personalizing conservative lymphedema management using indocyanine green-guided manual lymphatic drainage. Lymphat Res Biol 2021; 19 (01) 56-65
    CrossrefPubMedGoogle Scholar